Farther Finance Advisors’s Medifast MED Stock Holding History

Farther Finance Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$573	Buy	54 +11	+26%	+$127	﹤0.01%	5507
2026 Q1	$434	Buy	+43	New	+$464	﹤0.01%	5301
2025 Q4	–	Sell	-64	Closed	-$875	–	5539
2025 Q3	$875	Buy	+64	New	+$894	﹤0.01%	4406
2025 Q1	–	Sell	-4	Closed	-$70	–	4356
2024 Q4	$70	Hold	4	–	–	﹤0.01%	3838
2024 Q3	$77	Sell	4 -40	-91%	-$771	﹤0.01%	3819
2024 Q2	$925	Buy	44 +36	+450%	+$960	﹤0.01%	3104
2024 Q1	$300	Sell	8 -6	-43%	-$291	﹤0.01%	3168
2023 Q4	$941	Sell	14 -9	-39%	-$627	﹤0.01%	2764
2023 Q3	$1.72K	Buy	23 +4	+21%	+$355	﹤0.01%	1912
2023 Q2	$1.75K	Hold	19	–	–	﹤0.01%	1800
2023 Q1	$1.97K	Hold	19	–	–	﹤0.01%	1654
2022 Q4	$2.19K	Buy	+19	New	+$2.21K	﹤0.01%	1420

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Farther Finance Advisors's MED Position: Q2 2026 in Review

Farther Finance Advisors increased its Medifast (MED) stake by 26% in Q2 2026, buying an estimated $127 and bringing the position to 54 shares worth $573. The position accounts for ﹤0.01% of the portfolio, ranked #5507.

Farther Finance Advisors first reported a position in MED in Q4 2022 and has held it in 12 quarters since. The position peaked at $2.19K in Q4 2022. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Farther Finance Advisors held 54 shares of Medifast worth $573 as of Q2 2026.
Farther Finance Advisors bought 11 Medifast shares in Q2 2026, an estimated $127.
Medifast made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5507 holding.
Farther Finance Advisors first reported a position in Medifast in Q4 2022 and has held it in 12 quarters since.
Farther Finance Advisors's Medifast position peaked at $2.19K in Q4 2022.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.